Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for systemic inflammation in adult cystic fibrosis
NCT01092572Phase 2Withdrawn
- Sponsor
- University of British Columbia
- Start
- May 2010
- Primary completion
- May 2010
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of simvastatin in cystic fibrosis (CF) and systemic inflammation, sponsored by University of British Columbia. Primary endpoint: C-reactive protein at 12 weeks. Planned start May 2010; status: withdrawn.
02
Drugs
simvastatin
03
Conditions
cystic fibrosis (CF)systemic inflammation
Beyond the preview
Go deeper on NCT01092572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092572.